研报重点内容总结:
永新股份发布2023年中报,公司产业链一体化布局,盈利能力稳健提升。公司彩印和塑料薄膜业务增长稳健,且公司积极开拓海外市场,彩印销量受原材料价格影响呈下降趋势,薄膜业务受原材料价格影响较大。公司加强国际合作,外销表现靓丽。此外,公司毛利率水平维持在较高位置,净利率水平有所提高。盈利预测与投资评级为“买入”,维持“买入”评级。
report summary:
Yingxin Securities Research Institute issued a report on yuanlong chemical, and the company's earnings increased steadily in 2023上半 年. The company's revenue reached 16.05 billion yuan, up 4.7% from a year ago, and its net profit reached 1.77 billion yuan, up 20.0% from a year ago. The company's caiyu business expanded overseas, and the company's产业链一体化布局 improved its盈利能力. The company's caiyu and plastic film business showed a steady growth, but the pressure from the decline in oil prices also affected the company's earnings. The company's sales and marketing efforts remained strong, and its foreign sales also showed a promising performance. The company's gross margin and net profit margin both increased, mainly due to the stable cost structure, low-carbon growth, and foreign high-margin businesses. The company also actively expanded its overseas market and improved its产业链 layout. Looking at the future, the company's caiyu and plastic film business is expected to grow steadily, and the company's foreign sales will also continue to expand, pushing its profit margins higher.
在发现报告(www.fxbaogao.com),您可以找到海量的专业研报。作为国内用户量巨大的专业平台,我们覆盖了宏观、行业、公司等全方位内容,报告多到超乎您的想象。我们深知金融人的需求,用最简单的界面和最快的技术,帮您解决找资料难的问题。在这里,信息获取变得异常高效,让您轻松洞察市场,做出聪明的投资决定。
公司发布2023年中报:2023H1实现收入16.05亿元(同比+4.7%),归母净利润1.77亿元(同比+20.0%),扣非归母净利润1.70亿元(同比+23.5%);
单Q2实现收入8.20亿元(同比+1.4%),归母净利润0.99亿元(同比+20.3%),扣非归母净利润0.94亿元(同比+22.2%)。需求疲软叠加原材料降价、公司销量逆势保持稳健增长,均价小幅下降;公司积极扩张海外市场,原材料低位、产业链布局完善共驱盈利能力稳健提升。
彩印盈利稳健提升,塑料薄膜承压。2023H1彩印/镀铝包装/塑料薄膜/油墨分别实现收入12.50/0.23/1.91/0.72亿元(同比+4.8%/-19.0%/-4.9%/+4.0%),毛利率分别为26.9%/1.8%/1.4%/25.5%(同比+6.0/-3.6/-12.7/+4.9pct)。公司彩印销量稳健增长,价格受原材料价格下行影响呈下降趋势;薄膜业务考虑去年高基数(透析膜产品高增),且同样受原材料价格下降影响,经营承压。展望下半年,预计彩印销量稳健恢复,且伴随BOPE/BOPP等薄膜新产品投产,公司产业链一体化布局逐步加强,盈利能力有望保持高位。
加强国际合作,外销表现靓丽。2023H1内销/外销分别实现收入13.29亿元/2.07亿元(同比+0.8%/+20.3%),毛利率分别为21.9%/32.5%(同比+3.0pct/+7.0pct)。尽管国内终端需求疲软,内销仍维系较强韧性,下半年伴随传统旺季来临,公司加快新品研发和推广应用,有望实现恢复性增长;
外销持续加强与跨国企业深入合作、扩张全球份额,并逐步突破东南亚市场,增速表现靓丽。
原材料低位、产业纵深延长,盈利能力稳健提升。2023H1毛利率为24.4%(同比+3.4pct),净利率为11.0%(同比+1.4pct);单Q2毛利率为24.4%(同比+3.2pct),净利率为12.1%(同比+1.9pct)。盈利能力改善主要系原材料维系低位(上游石油均价Q2同比/环比分别-29.8%/-4.0%)、海外高毛利业务占比提高,以及薄膜新产能投产后原材料自给能力进一步提升。
从费用表现来看,单Q2期间费用率为9.8%(同比+0.7pct),其中销售/管理/研发/财务费用率分别为1.4%/3.6%/4.6%/0.1%( 同比-0.03pct/-0.3pct/+0.3pct/+0.8pct)。
现金流短暂承压,营运能力稳定。2023H1净经营现金流为0.84亿元(同比-3.19亿元),单Q2为1.98亿元(同比-0.38亿元),现金流略承压主要系福费廷业务到期所致。营运能力方面,截至2023H1应收账款周转天数为61.87天(同比-1.07天),应付账款周转天数为39.62天(同比-4.08天),存货周转天数为50.35天(同比-1.91天)。
盈利预测与投资评级:预计2023-2025年公司归母净利润分别为4.3亿元、4.9亿元、5.6亿元,对应PE为11.7X、10.3X、9.0X,维持“买入”评级。
风险提示:原材料价格波动,下游需求复苏不及预期。
财务指标
财务报表和主要财务比率
资产负债表(百万元)
现金流量表(百万元)